EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bolt Biotherapeutics's enterprise value is $-39.84 Mil.
Bolt Biotherapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7.88 Mil. Therefore, Bolt Biotherapeutics's EV-to-Revenue for today is -5.06.
The historical rank and industry rank for Bolt Biotherapeutics's EV-to-Revenue or its related term are showing as below:
BOLT'
s EV-to-Revenue Range Over the Past 10 Years
Min: -243.02 Med: -8.35 Max: 6273.76
Current: -5.06
During the past 6 years, the highest EV-to-Revenue of Bolt Biotherapeutics was 6273.76. The lowest was -243.02. And the median was -8.35.
BOLT's EV-to-Revenue is ranked better than 95.83% of 1031
companies
in the Biotechnology industry
Industry Median: 7.91
vs BOLT: -5.06
Bolt Biotherapeutics EV-to-Revenue Historical Data
The historical data trend for Bolt Biotherapeutics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bolt Biotherapeutics's EV-to-Revenue
For the Biotechnology subindustry, Bolt Biotherapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bolt Biotherapeutics's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bolt Biotherapeutics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Bolt Biotherapeutics's EV-to-Revenue falls into.
Bolt Biotherapeutics's current Enterprise Value is $-39.84 Mil.
Bolt Biotherapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bolt Biotherapeutics's share price for today is $1.10.
Bolt Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.21.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bolt Biotherapeutics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Bolt Biotherapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bolt Biotherapeutics (Bolt Biotherapeutics) Business Description
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOLT has been successfully added to your 